BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Lagos
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0100
TZNAME:WAT
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211027
DTEND;VALUE=DATE:20211030
DTSTAMP:20210923T213854Z
CREATED:20210923T213854Z
LAST-MODIFIED:20210923T213854Z
UID:49719-1635292800-1635551999@globalbiodefense.com
SUMMARY:GET Africa - Global Emerging Pathogens Treatment Consortium
DESCRIPTION:The 7th African Conference on One Health and Biosecurity  – GET Africa 2021 – will be held 27-29 October 2021 in Lagos\, Nigeria. \nGET was established in 2014 as a direct response to the 2014-16 Ebola virus disease outbreak in West Africa and ongoing outbreaks of Lassa Fever\, Meningitis\, Multidrug resistance (MDR) enteric fevers and Yellow Fever across the sub region. \n 
URL:https://globalbiodefense.com/event/get-africa-global-emerging-pathogens-treatment-consortium/
LOCATION:DE
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211028
DTEND;VALUE=DATE:20211030
DTSTAMP:20210924T224008Z
CREATED:20210924T224008Z
LAST-MODIFIED:20210924T224008Z
UID:49789-1635379200-1635551999@globalbiodefense.com
SUMMARY:Innovations in Pharmaceutical Manufacturing on the Horizon: A Virtual Dissemination Workshop
DESCRIPTION:Emerging technologies have the potential to modernize pharmaceutical manufacturing and advance the quality of drug products. \nThe National Academies of Sciences\, Engineering\, and Medicine; Division on Earth and Life Studies; Board on Chemical Sciences and Technology; Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing released a report which identifies these innovative technologies\, including manufacturing processes\, control and testing strategies\, and product technologies. \nThe report\, sponsored by the Food and Drug Administration Center for Drug Evaluation and Research\, also discusses technical and regulatory challenges to implementing these technologies and provides suggestions for how to overcome regulatory challenges. Join us for an upcoming virtual workshop where the pharmaceutical manufacturing community will discuss the report recommendations and strategies to advance the field. \nPlease visit NASEM’s Innovations in Pharmaceutical Manufacturing on the Horizon: A Virtual Dissemination Workshop website for more information. \n 
URL:https://globalbiodefense.com/event/innovations-in-pharmaceutical-manufacturing-on-the-horizon-a-virtual-dissemination-workshop/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211028T080000
DTEND;TZID=America/New_York:20211028T100000
DTSTAMP:20210924T231919Z
CREATED:20210924T231858Z
LAST-MODIFIED:20210924T231919Z
UID:49793-1635408000-1635415200@globalbiodefense.com
SUMMARY:Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication: Committee Meeting 5
DESCRIPTION:In this fifth meeting of the committee on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication\, the committee will meet in closed session to discuss the structure and content of the report\, and will establish a plan for the committee’s activities moving forward.\n\n\n\nAs part of this evaluation\, the committee will suggest a community engagement strategy for developing an international network of scientists to address claims about biological threats resulting from inaccurate and misleading information. Specifically\, this activity will: \n\nEvaluate existing online platforms and virtual communities for sharing information about and analyzing data from biological events including emerging outbreaks\, and current approaches for community-based review of scientific publications\, blog posts\, and other materials in this topical area.\nExplore key considerations for developing an international community or network of scientists to address the veracity of claims relating to biological threats. Considerations may include evaluation of the scientific qualifications of participants\, the accuracy and objectivity of analytic results\, transparency and integrity of analyses and peer review\, protection of scientists seeking to contribute to the community\, sustainability of the community\, and communication of scientific results.\nIncorporate knowledge from social and behavioral science fields in addressing network development and influence\, and community-based interactions in online settings.\nDevelop a community engagement strategy for establishing an international network of scientists to evaluate the credibility of reported biological threats. The strategy would incorporate lessons observed from existing platforms and approaches\, and include suggestions for organizational structures\, hosts and sustainability.\n\nThis project will involve the production of a short consensus report that will summarize the study findings and the suggested engagement strategy. The report and strategy to develop the network will be directed toward organizations involved in bioengagement activities and/or the broader scientific community. \nSubmit Input: Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication \nSubmit your ideas to the National Academies’ study on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication.  More information can be found on the study webpage.
URL:https://globalbiodefense.com/event/addressing-inaccurate-and-misleading-information-about-biological-threats-through-scientific-collaboration-and-communication-committee-meeting-5/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211028T140000
DTEND;TZID=America/New_York:20211028T150000
DTSTAMP:20210226T162359Z
CREATED:20210226T162359Z
LAST-MODIFIED:20210226T162359Z
UID:48675-1635429600-1635433200@globalbiodefense.com
SUMMARY:A Family Drama: The Sexual Politics of Smallpox Vaccination in the Spanish Empire
DESCRIPTION:The National Institutes of Health COVID-19 Scientific Interest Group will host a webcast entitled “A Family Drama: The Sexual Politics of Smallpox Vaccination in the Spanish Empire” on October 28\, 2021. \nIn 1804\, the Spanish Crown introduced the smallpox vaccine to its empire\, along with orders that vaccination be voluntary and that parents had a right to consent. Yet as families weighed the meaning of this decision\, doctors turned to the slave trade\, securing the vaccine and its future through bondage. \nAnalyzing this polemic and the politicization of preventative health\, my talk draws on collections of the NLM History of Medicine Division\, including institutional regulations and vaccination rosters from the Spanish Americas\, to trace the vaccine through the greater Caribbean and ask how and why colonial authorities selectively protected voluntary vaccination. \nForegrounding the methods by which the Spanish sought parental consent\, I examine the expectations about parenthood\, childrearing\, and the family that underscored their efforts\, demonstrating how long-standing investments in a patriarchal familial order were reanimated through the conservation and dissemination of the vaccine. In doing so\, the talk highlights the racial and sexual politics of vaccination and its contested relationship to slavery\, freedom\, and motherhood in the Atlantic World. \nAbout the Speaker \nFarren Yero\, PhD\, Postdoctoral Associate\, Gender\, Sexuality\, and Feminist Studies\, Duke University\, NIH \nPlease visit the NIH VideoCast website for more information.
URL:https://globalbiodefense.com/event/a-family-drama-the-sexual-politics-of-smallpox-vaccination-in-the-spanish-empire/
LOCATION:https://videocast.nih.gov/watch=41228
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211029T110000
DTEND;TZID=America/Los_Angeles:20211029T120000
DTSTAMP:20210925T161513Z
CREATED:20210925T161423Z
LAST-MODIFIED:20210925T161513Z
UID:49834-1635505200-1635508800@globalbiodefense.com
SUMMARY:Vaccine Hesitancy and the Anti-Vaxxer Movement
DESCRIPTION:Dr. Peter Hotez weighs in on identifying innovative strategies to tackling vaccine hesitancy and the anti-science movement. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nABOUT THE SPEAKER \nPeter Hotez\, M.D.\, Ph.D.\nBaylor College of Medicine \nPeter J. Hotez\, M.D.\, Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine. He is also the Co-Director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics.  He is also University Professor at Baylor University\, Fellow in Disease and Poverty at the James A Baker III Institute for Public Policy\,  Senior Fellow at the Scowcroft Institute of International Affairs at Texas A&M University\, Faculty Fellow with the Hagler Institute for Advanced Studies at Texas A&M University\, and Health Policy Scholar in the Baylor Center for Medical Ethics and Health Policy. He is the author of Forgotten People\, Forgotten Diseases (ASM Press/Wiley). \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/vaccine-hesitancy-and-the-anti-vaxxer-movement/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211104
DTSTAMP:20210930T162552Z
CREATED:20210930T162552Z
LAST-MODIFIED:20210930T162552Z
UID:49950-1635724800-1635983999@globalbiodefense.com
SUMMARY:Africa CDC Inaugural One Health Conference
DESCRIPTION:The Africa CDC Inaugural One Health Conference taking place virtually from 1 – 3 November 2021. \nOne Health is a collaborative\, multisectoral and transdisciplinary approach used to attain optimal health outcomes for people\, animals\, plants\, and their shared environment. Practically\, One Health involves the collaboration between human\, animal\, and environmental health sectors as well as other relevant stakeholders\, in the design and implementation of programmes\, policies\, legislation\, and research intended to achieve better health outcomes for all. \nTo celebrate and share the various One Health work taking place on the continent\, the Africa Centres for Disease Control and Prevention (Africa CDC) is hosting a 3-day virtual One Health Conference from 1-3 November 2021. The conference aims to: \n\nShare best practices and experiences from Member States and partners.\nShowcase continental One Health research focusing on zoonotic disease surveillance and outbreak investigations\, antimicrobial resistance\, food safety\, environmental health\, and operational research through scientific presentations.\nHighlight operational tools and guidance documents developed by African Union organs and technical partners like WHO\, OIE and FAO.\nExhibit opportunities for collaboration or One Health implementation support.\nStrengthen One Health advocacy and capacity across the AU Member States and Regional networks.\n\nPresenters will include representatives from Africa Union Member States\, RECs\, Africa Union technical agencies\, Africa CDC RCCs\, research institutions and technical partners. \nThis conference is hosted by Africa CDC in association with SBS Conferences & Exhibitions. \nQueries may be directed to info@sbs.co.za or +27 (0)71 348 1780. Registration is FREE and open to anyone interested in or involved in the field of One Health on the African continent. \nPlease visit the Africa CDC Inaugural One Health Conference website for more information. \n 
URL:https://globalbiodefense.com/event/africa-cdc-inaugural-one-health-conference/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/09/africa-cdc-one-health-conference.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211105
DTSTAMP:20210924T232710Z
CREATED:20210924T232546Z
LAST-MODIFIED:20210924T232710Z
UID:49795-1635724800-1636070399@globalbiodefense.com
SUMMARY:Eighth Arab-American Frontiers of Science\, Engineering\, and Medicine Symposium
DESCRIPTION:The Arab-American Frontiers program brings together outstanding young scientists\, engineers\, and medical professionals from the United States and the 22 countries of the Arab League for a series of symposia to discuss exciting advances and opportunities in their fields. \nDue to ongoing concerns surrounding the new COVID-19 variant\, the Eighth Symposium will now take place online\, November 1-4\, 2021. \nThe goal of these meetings is to enhance the scientific exchange and dialogue among young researchers in Arab countries and the United States\, including the Arab science diaspora\, and through this interaction\, facilitate research collaboration within and beyond the region. \nThe eighth symposium will discuss advances across a broad range of multi-disciplinary topics through five plenary sessions. These sessions are: \n\nSession I: Advanced Materials\nSession II: e-Health\nSession III: Water\, Food\, Environment\nSession IV: Cybersecurity\nSession V: Emerging Technologies and Society\n\nHighlighted topics include: \n\nApplying Patient and Public Health Data for Pandemic Response and Health Security (TBC)\nFrom Drones to Dentures: How Novel Materials are Increasing the Adoption of 3d Printing Across Every Industry\nApplications of Smart Wearable Devices in Health: Data\, Policy\, and Security Considerations\n\nThis symposium is made possible by the generous support of USAID\, Hamad bin Khalifa University\, and the National Science Foundation.
URL:https://globalbiodefense.com/event/eighth-arab-american-frontiers-of-science-engineering-and-medicine-symposium/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20210812T192722Z
CREATED:20210812T192722Z
LAST-MODIFIED:20210812T192722Z
UID:49489-1635897600-1636070399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2021 – BID2021
DESCRIPTION:This BARDA Industry Day 2021 Virtual Event will be held 3-4 November 2021. \nThis annual gathering of more than 1300 stakeholders from the public and private sector provides an opportunity to increase understanding of the U.S. government medical countermeasure priorities and funding goals; interact with BARDA and ASPR staff; and showcase innovations. \nInnovators may apply for limited openings to present during Lightning Talks sessions. Lightning Talks are for individuals\, academic institutions\, pharmaceutical companies\, biotech\, and other industry innovators to showcase their innovative technologies. \nTo submit your application for the Lightning Talks\, please enter the requested information and provide a brief (maximum 500 words) summary of your proposed presentation\, with one optional PowerPoint slide\, by 16 August. \nVisit the BARDA Industry Day website for more information. \n  \n 
URL:https://globalbiodefense.com/event/barda-industry-day-2021-bid2021/
LOCATION:
CATEGORIES:Conference,Government Hosted,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/bid-2021-barda-industry-day.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20211014T233809Z
CREATED:20211014T233450Z
LAST-MODIFIED:20211014T233809Z
UID:50256-1635984000-1636156799@globalbiodefense.com
SUMMARY:NIH 2021 Synthetic Biology Consortium
DESCRIPTION:The 2021 Annual Synthetic Biology Consortium Meeting will take place in virtual format from November 4-5\, 2021. \nThe 2021 Synthetic Biology Consortium Meeting will facilitate networking and collaboration among synthetic biology investigators. Attendees can use this meeting to collaborate with each other on current topics in synthetic biology and engage with NIH program directors. \nHighlighted presenters and panelists include: \n\nKaren Elkins\, FDA\, Center for Biologics Evaluation and Research\nMichelle Bond\, NIGMS\, Division of Pharmacology\, Physiology\, and Biological Chemistry\nTuba Fehr\, NICHD\, Development Biology and Structural Variation Branch\nTim Lu\, Massachusetts Institute of Technology\nGary Lee\, Senti Biosciences\nStephanie Morris\, NHGRI\, Division of Genome Sciences\nBrigitte Sanders\, NIAID\, Division of AIDS\nHye-Sook Kim\, NCCIH\, Basic and Mechanistic Research\nTatjana Atanasijevic\, NIBIB\, Division of Applied Science and Technology (Bioimaging)\nParijat Bhatnagar\, SRI International\nJoshua Leonard\, Northwestern University\nTara Deans\, The University of Utah\nDave Rampulla\, NIBIB\, Division of Discovery Science and Technology (Bioengineering)\nRahul Thakar\, NHLBI\, Advanced Technologies and Surgery Branch\nRyan Richardson\, NINDS\, Office of the BRAIN Director\nJerry Li\, NCI\, Structural Biology and Molecular Applications Branch\nKelly Crotty\, NCI\, Center for Strategic Scientific Initiatives\nJiahe Li\, Northeastern University\nTal Danino\, Columbia University\nAndrew Ellington\, University of Texas at Austin\nOphelia Venturelli\, University of Wisconsin-Madison\n\nPlease visit NIH’s 2021 Synthetic Biology Consortium meeting site for more information. \n 
URL:https://globalbiodefense.com/event/nih-2021-synthetic-biology-consortium/
LOCATION:https://www.zoomgov.com/meeting/register/vJItfu-hpzIiHqmy-7yogDu9ImlF2Lfd0iE
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211105T090000
DTEND;TZID=America/New_York:20211105T101500
DTSTAMP:20211004T004515Z
CREATED:20211004T004515Z
LAST-MODIFIED:20211004T004515Z
UID:50031-1636102800-1636107300@globalbiodefense.com
SUMMARY:Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations
DESCRIPTION:The Center for Global Development will host an online event on Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations on 5 Nov 2021. \nSince the early days of the COVID-19 pandemic\, many institutes have been using epidemiological modelling to predict the spread of the novel coronavirus as well as estimate the impact of different control measures. \nWith the development of multiple vaccine candidates\, new questions have now arisen as to how policymakers can ensure cost-effective COVID-19 vaccine deployment and allocation that considers both operational constraints (e.g.\, in-country cold chain or human resources for healthcare capacity) and epidemiological characteristics (e.g.\, seroprevalence\, social mixing\, age-stratification\, comorbidities\, vaccine stretching etc). \nIn this event\, study groups will present and disseminate results that tackle a diverse range of research questions focusing on COVID19 vaccine deployment and allocation. A wider discussion will follow focussing on how decision makers can consider epidemiological and operational modelling evidence to inform cost-effective COVID-19 vaccine deployment and allocation and highlight potential future steps and generalisable lessons for many lower resource settings. \nPRESENTERS \n\nNimalan Arinaminpathy\, Professor in Mathematical Epidemiology\, Imperial College London\nSarang Deo\, Professor\, Indian School of Business\nSripad Devalkar\, Associate Professor of Operations Management\, Indian School of Business\n\nPlease visit the Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations event site to register.
URL:https://globalbiodefense.com/event/allocating-scarce-covid-19-vaccines-based-on-epidemiological-and-operational-considerations/
LOCATION:https://www.youtube.com/watch?v=fBrn7Ayos2U
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211108T120000
DTEND;TZID=America/New_York:20211108T150000
DTSTAMP:20210925T002112Z
CREATED:20210925T002112Z
LAST-MODIFIED:20210925T002112Z
UID:49797-1636372800-1636383600@globalbiodefense.com
SUMMARY:Impact of and Response to the Pandemic: Webinar 1
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/impact-of-and-response-to-the-pandemic-webinar-1/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211111
DTEND;VALUE=DATE:20211114
DTSTAMP:20210226T211932Z
CREATED:20210226T211804Z
LAST-MODIFIED:20210226T211932Z
UID:48685-1636588800-1636847999@globalbiodefense.com
SUMMARY:APCCMI 2021 - Asia Pacific Congress of Clinical Microbiology and Infection
DESCRIPTION:The APCCMI 2021 Asia Pacific Congress of Clinical Microbiology and Infection will take place 11-13 November 2021 in Singapore and through virtual offerings. \nAPCCMI is the biennial conference for the Asia Pacific Society of Clinical Microbiology and Infection (APSCMI). \nHighlighted topics include: \n\nMERS CoV\, avian influenza and other respiratory viruses\nTransplant infectious diseases\nAdvances in rapid diagnostics\nAdvances in influenza therapeutics\nOne Health in infectious diseases\nMalaria and vector borne infections\nHot topics in antimicrobial stewardship\nTuberculosis and mycobacteria\nUtility of genome sequencing\nClinical implications of microbiome\n\nWho should attend? \nInfectious disease doctors\, trainees and scientists\nClinical and laboratory microbiologists\nInfection control professionals including doctors\, nurses and epidemiologists\nOutbreak control professionals including doctors\, epidemiologists and policy makers\nPharmacists and pharmacologists\nScientists and students undertaking research in the related fields\nVaccine professionals including doctors\, nurses\, pharmacists and policy makers \nPlease visit the APCCMI 2021 website for more information.
URL:https://globalbiodefense.com/event/apccmi-2021-asia-pacific-congress-of-clinical-microbiology-and-infection/
LOCATION:Suntec Singapore Convention Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211112T083000
DTEND;TZID=America/New_York:20211112T133000
DTSTAMP:20211111T190139Z
CREATED:20211101T175106Z
LAST-MODIFIED:20211111T190139Z
UID:50918-1636705800-1636723800@globalbiodefense.com
SUMMARY:The Future of Malaria Research Symposium
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12\, prior to the American Society of Tropical Medicine and Hygiene’s annual meeting. \nStudents\, postdoctoral researchers\, and early career scientists are encouraged to submit an abstract to be considered for a short or long talk. Dr. Etienne Bilgo\, Postdoctoral Fellow in Biomedical Sciences at the Institut de Recherche en Science de la Santé-IRSS/Centre Muraz will deliver the keynote address. Organized by postdocs and students\, the event will be held via Zoom and scientists at all career levels are encouraged to attend. \nHighlighted topics include: \n\nVectorCAM: a low cost hand held tool for automated\, rapid morphological identification of mosquito species\nIdentification of a novel determinant associated with quinine resistance in a Plasmodium falciparum genetic cross\nModeling the emergence of piperaquine-resistant Plasmodium falciparum malaria in Africa\nMitochondrial multidrug resistant transporter (MDR6) and its interaction with the ISC pathway in Plasmodium falciparum\nInappropriate sales of antimalarials in private-sector drug shops in rural Uganda\nA modular cloning system for high efficiency production of Plasmodium falciparum transfection vectors\nEvaluating the effects of sorbitol synchronization of clinical isolates of Plasmodium falciparum on their susceptibility to antimalarial compounds\nComparison of overnight to early evening malaria vector collections in indoor setting in Nchelenge District\, Zambia\nNovel kinases play an essential role during asexual proliferation of Plasmodium falciparum parasites”\nImpacts of a 4.3kb structural variant on gene expression and insecticide resistance phenotype in the malaria vector An. funestus s.s.\nFactors associated with asymptomatic recurrences due to Plasmodium vivax infection after radical cure treatment in communities in the Peruvian Amazon\nOctopi: a ready-to-deploy high-throughput imaging solution for malaria management and malaria research\nDistinct antibody responses to Plasmodium antigens reveal candidate biomarkers of the intensity and timing of past exposure to malaria\nAn ex vivo model of oxidatively stressed red blood cells demonstrates a role for exogenous amino acids in enhancing bystander red blood cell function and morphology in malaria\nSystems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria\nA Male-Drive Female-Sterile (MDFS) system in Anopheles gambiae targeting doublesex\nAssessing the use of microRNAs for the diagnosis of severe falciparum malaria\nPrevalence of Plasmodium falciparum submicroscopic infection and pregnancy outcomes in Congolese women at delivery\nUsing transgenic fungi to kill malaria mosquitoes\nConditional knockdown of essential proteins in P. falciparum Midgut Stages\nA semi-field system for quantitative tracking of Anopheles gambiae olfactory preferences\nEstimating the impact of RTS\,S deployment in areas with seasonal malaria chemoprevention\nTrends in falciparum malaria prevalence\, parasite density and associated risk factors in Akure\, Southwestern Nigeria: An implication for malaria elimination\nAssessing off-target effects of CRISPR-Cas9 based gene drives in Anopheles gambiae\nHeritable cultivable bacteria associated to wild Anopheles gambiae s.l. in Burkina Faso for paratransgenic control perspectives of malaria\n\nPlease visit the Johns Hopkins Bloomberg School of Public Health 7th Future of Malaria Research Symposium website for more information.
URL:https://globalbiodefense.com/event/the-future-of-malaria-research-symposium/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211118
DTSTAMP:20211111T211702Z
CREATED:20211101T201407Z
LAST-MODIFIED:20211111T211702Z
UID:50931-1637020800-1637193599@globalbiodefense.com
SUMMARY:Developing a Long-Term Strategy for Low-Dose Radiation Research in the U.S.
DESCRIPTION:This meeting hosted by the National Academies will focus on receiving information from the research community on low dose radiation research priorities and lessons to be learned from managing multidisciplinary programs. \n\nWhat are your views on research priorities for low dose radiation research?\nHow can epidemiology contribute to further understanding risks?\nMolecular approaches to improve understanding of DNA repair following low dose radiation exposures\nAdvancements in dosimetry to support radiation epidemiology\nEpigenetic changes and their applications to radiation epidemiology\nClonal hematopoiesis and space radiation\nTechniques used to identify functional elements of the microbiome\nOpportunities and challenges for epigenetics and microbiome research in low dose radiation exposures\nOverview of studies of in utero exposure to radiation with emphasis on low doses\nLimitations of low-dose epidemiological studies\nModeling radiation effects including radiation carcinogenesis\, normal tissue complications\, radioresistance and non-targeted effect\nMethods and tools to estimate radiation dose in low dose radiation studies of medical\, occupational\, and environmental exposures\nMethods to study immune response and its role in cancer development and treatment\nModern techniques for mapping cells carrying mutations in normal tissues\n\nPlease visit NASEM’s Developing a Long-Term Strategy for Low-Dose Radiation Research in the United States: Meeting 6\, November 16-17\, 2021 website for more information.
URL:https://globalbiodefense.com/event/developing-a-long-term-strategy-for-low-dose-radiation-research-in-the-u-s-2/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T090000
DTEND;TZID=America/New_York:20211116T160000
DTSTAMP:20211111T192222Z
CREATED:20211104T181912Z
LAST-MODIFIED:20211111T192222Z
UID:50927-1637053200-1637078400@globalbiodefense.com
SUMMARY:Enhanced Drug Distribution Security at the Package Level
DESCRIPTION:The FDA will hold a virtual public meeting on November 16\, 2021\, on enhanced drug distribution security at the package level. \nThe purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug distribution security provisions of the Drug Supply Chain Security Act (DSCSA) that go into effect in 2023. \nFDA requests that stakeholders prepare comments responding to the following questions for one or more of the topics listed below: \n\nHow is implementation of the 2023 enhanced system requirements progressing for your organization?\nWhat challenges is your organization facing?\nAre the proposed recommendations in FDA’s guidance on enhanced drug distribution security at the package level helpful to achieve compliance with 2023 enhanced system requirements? If not\, what additional information would be useful?\nAre there areas in which FDA could provide more clarity?\n\nTopics\n\nEnhanced Drug Distribution Security\n\nSystem Attributes\nAggregation\, Inference\, and Physical Security Features\n\n\nSystem Structure\n\nData Architecture\nAdoption of Data and System Security\nProtecting Confidential Commercial Information and Trade Secrets\nSystem Access and Data Retrieval\n\n\nEnhanced Product Tracing\n\nSerialized Transaction Information and Data Exchange (Incorporation of the Product Identifier into Product Tracing Information)\nResponsibilities of the Selling and Buying Trading Partners with regard to the Product Tracing Information\nHandling Aggregation Errors and Other Discrepancies\n\n\nGathering of Relevant Product Tracing Information\nEnhanced Verification\n\nVerification of Distributed Product\nVerification of Saleable Return Product\nAlerts for Illegitimate Product\n\n\nTrading Partner Readiness\n\nYour organization’s overall readiness for implementation\nComponents that your organization is furthest along in developing\, including the components being prioritized and the components that are easier or more challenging to implement\n\n\n\nAdditional Information\n\nEnhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act Draft Guidance for Industry\nFDA Webinar on October 5\, 2021: Enhanced Drug Distribution Security in 2023 Under the DSCSA
URL:https://globalbiodefense.com/event/enhanced-drug-distribution-security-at-the-package-level/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211117
DTEND;VALUE=DATE:20211122
DTSTAMP:20211111T191055Z
CREATED:20211102T180552Z
LAST-MODIFIED:20211111T191055Z
UID:50922-1637107200-1637539199@globalbiodefense.com
SUMMARY:ASTMH 2021 Annual Meeting
DESCRIPTION:The American Society for Tropical Medicine and Hygiene (ASTMH) will gather virtually from 17-21 November for the Annual Meeting of leaders and scientific experts invested in tropical medicine and global health. \nThe virtual gathering will feature a wide range of COVID-19 related work\, including reports on the potential protective effects of malaria\, new vaccine innovations and how pandemic safeguards have turned fevers into a dangerous stigma. Researchers also will present new findings on elimination efforts for a number of diseases\, such as leprosy and river blindness; probe whether a smartphone app can reveal a link between pandemic outdoor time and risks of tick-borne disease; and discuss potentially promising news on tamping down resurgent malaria\, including vaccine advances and progress against insecticide resistance. \nPlease visit the ASTMH 2021 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/astmh-2021-annual-meeting/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211118T120000
DTEND;TZID=America/New_York:20211118T150000
DTSTAMP:20210925T002459Z
CREATED:20210925T002459Z
LAST-MODIFIED:20210925T002459Z
UID:49800-1637236800-1637247600@globalbiodefense.com
SUMMARY:Recovery and Resilience: Webinar 2
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/recovery-and-resilience-webinar-2/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T090000
DTEND;TZID=America/New_York:20211130T170000
DTSTAMP:20211111T191610Z
CREATED:20211111T191610Z
LAST-MODIFIED:20211111T191610Z
UID:50925-1638262800-1638291600@globalbiodefense.com
SUMMARY:Antimicrobial Drugs Advisory Committee (AMDAC) Meeting
DESCRIPTION:The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. \nFDA intends to make background material available to the public no later than two (2) business days before the meeting. \nBackground material and the link to the online teleconference meeting room will be available at 2021 Meeting Materials\, Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \nFDA is establishing a docket for public comment on this meeting. The docket number is FDA-2021-N-0758. The docket will close on November 29\, 2021. Submit either electronic or written comments on this public meeting by November 29\, 2021. \nComments received on or before November 15\, 2021\, will be provided to the committee(s). Comments received after that date but by November 29\, 2021\, will be taken into consideration by FDA. \nLearn more at the FDA meeting announcement website. \n  \n 
URL:https://globalbiodefense.com/event/antimicrobial-drugs-advisory-committee-amdac-meeting/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T130000
DTEND;TZID=America/New_York:20211130T153000
DTSTAMP:20210925T002821Z
CREATED:20210925T002750Z
LAST-MODIFIED:20210925T002821Z
UID:49802-1638277200-1638286200@globalbiodefense.com
SUMMARY:Prevention and Preparedness: Webinar 3
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/prevention-and-preparedness-webinar-3/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211203
DTEND;VALUE=DATE:20211204
DTSTAMP:20210226T214741Z
CREATED:20210226T214741Z
LAST-MODIFIED:20210226T214741Z
UID:48694-1638489600-1638575999@globalbiodefense.com
SUMMARY:One Health: Integrating Human\, Animal and Environmental Health
DESCRIPTION:A virtual science conference on One Health: Integrating Human\, Animal and Environmental Health will be held 3 December 2021. \nThe One Health movement\, which has come to prominence in the last decade\, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to both animal and environmental health\, and that issues such as population growth\, changes in climate and land use\, and the movement of animals and people\, have a huge impact on the collective health of our world today. \nPlease visit EMBL’s One Health: Integrating Human\, Animal and Environmental Health page for more information.
URL:https://globalbiodefense.com/event/one-health-integrating-human-animal-and-environmental-health/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211208T090000
DTEND;TZID=America/New_York:20211208T103000
DTSTAMP:20240623T192553Z
CREATED:20211005T192345Z
LAST-MODIFIED:20240623T192553Z
UID:50043-1638954000-1638959400@globalbiodefense.com
SUMMARY:Current Concepts in Quantitative Risk Assessment for Skin Sensitization
DESCRIPTION:The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” \nThe next webinar in the series on December 8 will consider the topics of methods for skin sensitization hazard and potency determination using currently available non-animal test methods\, as well as exposure assessment and quantification. \nThe webinar series is free and open to the public. Those who registered to view the first webinar are automatically registered for the second webinar. \nInformation and a link to register are available at https://ntp.niehs.nih.gov/go/ssqra-web. A video from the first webinar in the series\, which presented an introduction to skin sensitization and contact dermatitis\, will be posted on this page when available. \nRegister for the December 8 webinar: “Methods for hazard and exposure assessment”
URL:https://globalbiodefense.com/event/current-concepts-in-quantitative-risk-assessment-for-skin-sensitization/
LOCATION:
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211217
DTSTAMP:20211106T220805Z
CREATED:20211106T220727Z
LAST-MODIFIED:20211106T220805Z
UID:50876-1639612800-1639699199@globalbiodefense.com
SUMMARY:National Biodefense Science Board Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16\, 2021\, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness\, response\, and recovery. \n\n\n\nA more detailed agenda will be available on the NBSB meeting website https://www.phe.gov/​nbsb. \n\n\n\nProcedures for Public Participation\n\n\n\nMembers of the public may attend the meeting via a toll-free phone number or Zoom teleconference\, which requires pre-registration. The meeting link to pre-register will be posted on the meeting website https://www.phe.gov/​nbsb. Members of the public may provide written comments or submit questions for consideration by the NBSB at any time via email to NBSB@hhs.gov. \nSource: Federal Register Notice
URL:https://globalbiodefense.com/event/national-biodefense-science-board-meeting/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220114T103000
DTEND;TZID=America/New_York:20220114T173000
DTSTAMP:20211111T212345Z
CREATED:20211111T212345Z
LAST-MODIFIED:20211111T212345Z
UID:50933-1642156200-1642181400@globalbiodefense.com
SUMMARY:Lessons Learned from the COVID-19 Pandemic to Improve Diagnosis
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will convene a virtual workshop on January 14\, 2022 to examine changes to diagnostic paradigms in response to the COVID-19 pandemic and to consider the lessons learned and opportunities for improving diagnosis within the U.S. health care system. \nThe workshop will be accessible to the public via live webcast. Please register online to receive an email with the instructions on how to join this workshop. \nPlanning Committee: \n\nDerek Angus\, (Co-chair)\, University of Pittsburgh\nAndrew Bindman (Co-chair)\, Kaiser Permanente\nAmesh Adalja\, Johns Hopkins Center for Health Security\nSuzanne Bakken\, Columbia University\nMarie-Carmelle Elie\, University of Alabama School of Medicine\nNicole Lurie\, Coalition for Epidemic Preparedness Innovations\nKathryn McDonald\, Johns Hopkins University\nKosali Simon\, Indiana University\nSaul Weingart\, Rhode Island Hospital and Brown University\n\nPlease visit NASEM’s Advancing Diagnostic Excellence: A Workshop Series website for more information. \n 
URL:https://globalbiodefense.com/event/lessons-learned-from-the-covid-19-pandemic-to-improve-diagnosis/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220211
DTSTAMP:20211111T221529Z
CREATED:20211111T221529Z
LAST-MODIFIED:20211111T221529Z
UID:50938-1644364800-1644537599@globalbiodefense.com
SUMMARY:Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity
DESCRIPTION:The National Academies will host a meeting 9-10 February 2022 to discuss the current understanding of animal welfare challenges in research on wildlife and biologically diverse vertebrate animal species.  \nResearch to advance understanding of the ecology and biology of wildlife species is more important than ever as the world confronts issues ranging from biodiversity loss to the emergence of zoonotic diseases. \nThis workshop will focus on issues associated with the unique welfare challenges of conducting research with biologically diverse vertebrates living in varied habitats\, for which guidance resources on wildlife research sometimes conflict and recommendations outlined in the current version of the Guide for the Care and Use of Laboratory Animals (8th edition) can present challenges. \nThe workshop will include presentations and panel discussions to explore topics and questions\, such as: \n\nUnderstanding the growing needs of\, and building strategies for\, enhancing veterinary and Institutional Animal Care and Use Committee (IACUC) expertise on the health and welfare of wildlife and biologically diverse vertebrate animal species;\nDiscuss resource options for improving the development and evaluation of IACUC protocols on research studies involving wildlife and biologically diverse vertebrate animal species interactions in captive and diverse natural environmental settings;\nDiscussing bioethics associated with fieldwork practices (e.g.\, bleeding\, euthanasia including thoracic compressions for small birds) and unique considerations for wildlife and biologically diverse vertebrate animal species; as well as welfare assessments amidst other considerations such as unique physiological\, behavioral\, environmental\, and/or husbandry needs of wildlife and biologically diverse vertebrate animal species;\nDiscussing federal\, state\, and local regulatory and management challenges associated with research on terrestrial and aquatic wildlife and biologically diverse vertebrate animal species;\nDiscussing opportunities for enhancing collaborations between IACUCs and researchers studying wildlife and biologically diverse vertebrate animal species\, including animal-environment interactions\, anthropogenic effects on environment and animal life\, and the relation between animal\, environmental\, and human health.\nDiscussing strategies\, synergies\, and collaborations within and among the wildlife and biologically diverse vertebrate animal research\, and biodiversity communities that could leverage national level research resources\, identify knowledge gaps\, and facilitate knowledge acquisition and sharing.\nReview the reasons and advantages for IACUC review of research using wildlife and biologically diverse vertebrate animal species\, including regulatory compliance\, public relations\, and institutional protection.\n\nPlease visit NASEM’s Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity website for more information.
URL:https://globalbiodefense.com/event/animal-welfare-challenges-in-research-and-education-on-wildlife-non-model-animal-species-and-biodiversity/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220307T133000
DTEND;TZID=America/New_York:20220307T150000
DTSTAMP:20220305T134424Z
CREATED:20220303T133528Z
LAST-MODIFIED:20220305T134424Z
UID:54171-1646659800-1646665200@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday\, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. \nJoin federal leaders\, National Biodefense Science Board members\, distinguished guests\, and other experts to discuss topics related to the public health supply chain and climate change.  NBSB will hear from the HHS Office of Climate Change and Health Equity and Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense (JPEO-CBRND) during the meeting. \nSubject matter experts from industry; academia; health systems; health consumer organizations; state\, local\, tribal\, and territorial public health; and emergency management agencies will also have an opportunity to provide comments to the NBSB on national priorities for biodefense and health security. Individual remarks will be limited to seven minutes each and the display of images and/or slides for public speakers will not be available. \nRequests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by March 4\, 2022. In that request\, please provide the speaker’s name\, title\, and position with a brief summary of planned comments. The number of speakers and topics will be based on relevance to the mission of the NBSB and amount of time available on the agenda.  Those selected for public comments will receive confirmation by email prior to the meeting date with additional instructions. \nRegistration for this event is required and can be accessed along with additional meeting information through the online event page.  We encourage you to share this engagement information broadly across your network in advance of the meeting. \nMeeting materials will be made available to the public on the National Biodefense Science Board webpage. For any additional information or questions specific to this event\, please contact NBSB@hhs.gov directly.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-3/
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_DdvW3yVpTuGWSIey8ZsfBg
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220322
DTEND;VALUE=DATE:20220325
DTSTAMP:20220225T203340Z
CREATED:20220225T203242Z
LAST-MODIFIED:20220225T203340Z
UID:54067-1647907200-1648166399@globalbiodefense.com
SUMMARY:ASPPH Annual Meeting 2022
DESCRIPTION:The Association of Schools and Programs of Public Health ASPPH Annual Meeting 2022 will be held online 22-24 March 2022. \nThe ASPPH Annual Meeting convenes academic public health leaders\, faculty\, students\, and members of the public health community from around the world for three days to engage in discussions and share new strategies and tools to strengthen education\, practice\, and research in public health. \nHighlighted topics include: \n\nEducation for Public Health in a Post-COVID World\nBuilding Trust in Public Health Emergency Preparedness and Response\nGlobal Governance for Health: The Role of Academic Public Health\nUsing ASPPH Data Resources for Academic Public Health Research\nUnderstanding and Responding to Health Misinformation and Disinformation\nThe Public Health Fulcrum: Convening for Multi-disciplinary and Interprofessional Education for Collaborative Practice\nUsing Digital Marketing for Engagement and Recruitment\nClimate Change and Health: The Defining Issue of Our Time\n\nPlease visit the ASPPH website for more information.
URL:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
LOCATION:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220327
DTEND;VALUE=DATE:20220401
DTSTAMP:20220325T155530Z
CREATED:20220225T165130Z
LAST-MODIFIED:20220325T155530Z
UID:54584-1648339200-1648771199@globalbiodefense.com
SUMMARY:SOT 2022 - Society of Toxicology Annual Meeting
DESCRIPTION:The 61st Annual Meeting of the Society of Toxicology will be held 27-31 March 2022 in San Diego\, California with livestream options for remote participation. \nThis year’s meeting will include all the traditional hallmarks—2\,000+ scientific presentations across 70+ sessions; 250 exhibitors with products and services in the ToxExpo; and scores of networking and social events. This year’s meeting will also feature a key new element that will enhance the meeting experience for all. Registrants not traveling to the meeting can watch all the Featured and Scientific Sessions live through the SOT Event App or Online Planner. Of note\, all registrants can access these same sessions through on-demand recordings that will be available in the SOT Event App and Online Planner after their conclusion. These on-demand videos will be viewable to registrants through July 31\, 2022. \nHighlighted sessions of interest include: \n\nConceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment\nAll for One and One for All: One Environmental Health in Toxicology\nMethodological Aspects of Vascular Toxicity\nPrinciples and Applications of Read-Across in Human Health Risk Assessment\nHow Advances in Exposure Science and Toxicology Are Changing Assessments of the Effects of Chemical Mixtures on Human Health\nLeading-Edge Microbiome Methods for Toxicological Applications\nApplications of Single Cell Profiling Methods to Enhance Mechanistic Understanding of Toxicological Responses\nNext-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping\nComparative Toxicology\, Pathology\, and Veterinary Specialty Section Officers Meeting\nAssay Gaps in the Developmental Neurotoxicity (DNT) New Approach Methodologies (NAMs) Battery for Human Health Risk Assessment\nApplication of the devTOX quickPredict and Cardio quickPredict Biomarker-Based In Vitro Assays for Toxicity Screening: Presented by Stemina Biomarker Discovery\nBiotechnology\, Mechanisms\, Molecular and Systems Biology Joint Specialty Section Mentoring Event\nSimulated-Use Extractables: A Risk Mitigation Strategy for Medical Device Toxicological Risk Assessments (TRAs): Presented by WuXi AppTec – Laboratory Testing Division\nBad Breath: Noninvasive Investigation into the Exhaled Biomarkers for Toxicological Research\nUp to the Task? Quantitative Evaluation Criteria for Physiologically Based Pharmacokinetic (PBPK) Models\n\nPlease include the following National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) activities in your itinerary for the first two days of the Society of Toxicology (SOT) 2022 annual meeting. A list of all NICEATM and ICCVAM activities is available here. For remote participants\, all times are Pacific Daylight Time. \nSunday\, March 27: Continuing Education Courses: \n\nAM02: Conceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment (8:15 a.m.-12 noon): Acting NICEATM Director Nicole Kleinstreuer is a speaker.\nPM11: Next-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping (1:15-5:00 p.m.): NICEATM scientist Helena Hogberg (National Institute of Environmental Health Sciences) is presenting.\n\nMonday\, March 28: Oral Presentation Sessions: \n\nSymposium Session: New Approach Methods for Functional Developmental Neurotoxicity (9:15 a.m.-12:00 noon – CC Ballroom 6E): ICCVAM advisory committee member Tamara Tal (Helmholtz Centre for Environmental Research) is session chair; Acting NICEATM Director Nicole Kleinstreuer is session co-chair.\nPlatform Session: Risk Assessment (9:15 a.m.-12:00 noon – CC Room 8): “Modification of the Skin Allergy Risk Assessment (SARA) Model for GHS Classification and Its Application to Isothiazolinone Case Studies\,” presented by NICEATM scientist Judy Strickland (Inotiv\, contractor supporting NICEATM).\n\nMonday\, March 28: Poster Sessions: \n\nPFAS I (9:00-10:45 a.m.)\nAutoimmunity/Hypersensitivity (2:30-4:15 p.m.)\nNeurotoxicity: General (2:30-4:15 p.m.)\nReproductive and Developmental Toxicology I (2:30-4:15 p.m.)\nFood Safety/Nutrition (2:30-4:15 p.m.)\n\nProof of COVID-19 vaccination is required to participate in the on-site meeting. \nPlease visit the SOT 2022 website to register and for more information. \n 
URL:https://globalbiodefense.com/event/sot-2022-society-of-toxicology-annual-meeting/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220331
DTSTAMP:20220322T155748Z
CREATED:20220322T155748Z
LAST-MODIFIED:20220322T155748Z
UID:54522-1648512000-1648684799@globalbiodefense.com
SUMMARY:Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science
DESCRIPTION:The National Academies’ Planning Committee on Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science will hold a workshop on 29-30 March. \nWorkshop discussants and participants will collaboratively generate actionable strategies and approaches to (re)build and maintain trust across this continuum\, across stakeholders\, across levels of the system (federal\, state\, tribal\, territorial\, and local)\, and across emergency types. Workshop discussants and participants will specifically: \n\nExamine why the topic of public trust (and trustworthiness\, credibility\, confidence in\, among others) is important in PHEPR science and develop a shared understanding of its importance and its relationship to other factors that contribute to social cohesion in public health emergencies.\nExplore key elements of PHEPR science communication and generate actionable communications strategies based on recent experiences.\nGenerate actionable strategies and approaches for building/maintaining trust\, communicating PHEPR science and the scientific process in the face of uncertainty and in response to the recent decline in perceived credibility of federal\, state\, and local agencies.\nExamine the ways in which diverse demographic groups experience PHEPR science differently and generate strategies and approaches for building trust in PHEPR science and the scientific process that is tailored to these varied experiences.\n\nWorkshop Planning Committee members include: \n\nSandra Quinn\, Ph.D.\, M.Ed. (Chair)\, University of Maryland\nDominique Brossard\, Ph.D.\, University of Madison-Wisconsin\nEsther Chernak\, M.D.\, M.P.H.\, FACP\, Drexel University\nKenny Hendrickson\, Ph.D.\, University of the Virgin Islands\nHilary Karasz\, Ph.D.\, M.A.\, Public Health – Seattle and King County\nJennifer Kiger\, M.P.H.\, LSSBB\, Harris County Public Health\nRachael Piltch-Loeb\, Ph.D.\, M.S.P.H.\, Harvard University\nKai Ruggeri\, Ph.D.\, Columbia University\nMonica Schoch-Spana\, Ph.D.\, Johns Hopkins University\nCathy Slemp\, M.D.\, M.P.H.\, Catherine C Slemp\, LLC
URL:https://globalbiodefense.com/event/building-public-trust-in-public-health-emergency-preparedness-and-response-phepr-science/
LOCATION:
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220330T130000
DTEND;TZID=America/New_York:20220330T153000
DTSTAMP:20220323T181737Z
CREATED:20220323T163049Z
LAST-MODIFIED:20220323T181737Z
UID:54546-1648645200-1648654200@globalbiodefense.com
SUMMARY:Inaugural Joint Meeting of NACSD and NACIDD
DESCRIPTION:Please join Assistant Secretary for Preparedness and Response Dawn O’Connell along with Assistant Secretary for Aging and Acting Administrator for Community Living Alison Barkoff\, Wednesday\, March 30 from 1:00 p.m. to 3:30 p.m. ET for the inaugural meeting of the National Advisory Committee on Seniors and Disasters (NACSD) and National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). \nAdvanced registration for this meeting is required and can be accessed\, along with additional meeting information\, through the online event page. \nDuring this joint meeting\, committee members will be sworn into service and begin a national discussion with federal subject matter experts on the challenges\, opportunities\, and priorities in meeting the unique health needs of older adult populations and people with disabilities during and after disasters and public health emergencies. \nThe agenda includes time to hear from the public. The floor will be open to hear as many relevant comments as possible. To learn how to request a speaking time\, please visit our event page. Meeting materials also will be made publicly available through that page. You can send questions about the NACSD to NACSD@hhs.gov and questions about the NACIDD to NACIDD@hhs.gov. \nBackground \nThe National Advisory Committee on Seniors and Disasters (NACSD) and the National Advisory Committee on Individuals With Disabilities and Disasters (NACIDD)\, or Committees\, were established by sections 2811B and 2811C\, respectively\, of the Public Health Service (PHS) Act\, as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) of 2019. The Committees are governed by the provisions of the Federal Advisory Committee Act (FACA) and the General Services Administration FACA Final Rule. The Committees evaluate issues and programs and provide findings\, advice\, and recommendations to the Secretary of HHS to support and enhance all-hazards public health and medical preparedness\, response\, and recovery. The NACSD provides focus on the unique needs of older adults\, while the NACIDD focuses on helping HHS meet the needs of people with disabilities (PWD). The Secretary of HHS has formally delegated authority to operate the NACSD and the NACIDD to ASPR. \nFor Further Information:\nDr. Maxine Kellman\, NACSD Designated Federal Official\, 202-260-0447\, NACSD@hhs.gov; Tabinda Burney\, NACIDD Designated Federal Official\, 202-699-1779\, NACIDD@hhs.gov. Office of the Assistant Secretary for Preparedness and Response (ASPR)\, Department of Health and Human Services (HHS)\, Washington\, DC. \nLearn more and register at the ASPR website \n 
URL:https://globalbiodefense.com/event/national-advisory-committee-on-seniors-and-disasters-nacsd-and-national-advisory-committee-on-individuals-with-disabilities-and-disasters-nacidd/
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_qCfSOHCWT4qTywRzWw_3fA
CATEGORIES:Conference,Government Hosted
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/nacidd-individuals-disabilities-disasters-seniors-disasters-aspr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T110000
DTEND;TZID=America/New_York:20220404T170000
DTSTAMP:20220321T200058Z
CREATED:20220321T200058Z
LAST-MODIFIED:20220321T200058Z
UID:54494-1649070000-1649091600@globalbiodefense.com
SUMMARY:Public Workshop on Use of Population Descriptors in Genomics Research
DESCRIPTION:The second meeting of the Committee on Use of Race\, Ethnicity\, and Ancestry as Population Descriptors in Genomics Research will be held on April 4 and April 7\, 2022. \nAs part of this workshop\, the committee request public comment on the current use of population descriptors such as race\, ethnicity\, ancestry\, etc. in genomics research and how the use of population descriptors could be improved upon in the future. \nThe agenda will be available on the event webpage. \nThe committee requests public comments as part of this workshop. The committee would like to hear from researchers\, advocates\, and any other interested stakeholders on how population descriptors are currently being used effectively in genomics research\, how they could be improved\, and what systems might be used effectively in the future. \nThe committee will invite a few authors representing a sample of the submissions to present their comments at the workshop on April 4th. If you wish to be considered as a speaker at this workshop\, please submit your comment by March 23rd. Authors of submission submitted after March 23rd may also be considered to be speakers at the workshop in the summer. \nClick here to learn more and submit your comment.
URL:https://globalbiodefense.com/event/public-workshop-on-use-of-population-descriptors-in-genomics-research/
LOCATION:https://bit.ly/nasem-genomics
CATEGORIES:Conference
END:VEVENT
END:VCALENDAR